SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001618835-20-000244
Filing Date
2020-11-18
Accepted
2020-11-18 17:04:39
Documents
13
Period of Report
2020-11-18
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K evfm_x11x18x2020xstifelpre.htm 8-K 25672
2 EX-99.1 a20201118_evfmpresentati.htm EX-99.1 19768
3 GRAPHIC a20201118_evfmpresentati001.jpg GRAPHIC 73969
4 GRAPHIC a20201118_evfmpresentati002.jpg GRAPHIC 228588
5 GRAPHIC a20201118_evfmpresentati003.jpg GRAPHIC 134911
6 GRAPHIC a20201118_evfmpresentati004.jpg GRAPHIC 115568
7 GRAPHIC a20201118_evfmpresentati005.jpg GRAPHIC 119439
8 GRAPHIC a20201118_evfmpresentati006.jpg GRAPHIC 81333
9 GRAPHIC a20201118_evfmpresentati007.jpg GRAPHIC 118138
10 GRAPHIC a20201118_evfmpresentati008.jpg GRAPHIC 133504
11 GRAPHIC a20201118_evfmpresentati009.jpg GRAPHIC 127827
12 GRAPHIC a20201118_evfmpresentati010.jpg GRAPHIC 132220
13 GRAPHIC a20201118_evfmpresentati011.jpg GRAPHIC 91708
  Complete submission text file 0001618835-20-000244.txt   1917116
Mailing Address 12400 HIGH BLUFF DRIVE SUITE 600 SAN DIEGO CA 92130
Business Address 12400 HIGH BLUFF DRIVE SUITE 600 SAN DIEGO CA 92130 (858) 550-1900
Evofem Biosciences, Inc. (Filer) CIK: 0001618835 (see all company filings)

IRS No.: 208527075 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36754 | Film No.: 201325853
SIC: 2834 Pharmaceutical Preparations